Awarded

Lote 2 - Panitumumab, Romiplostim, Etelcalcetida, Carfilzomib, Sotorasib, Inebilizumab
 Panitumumab, Romiplostim, Etelcalcetida, Carfilzomib, Sotorasib, Inebilizumab

Track this recordFree account — get alerted when a contract here runs out.
Winners
AMGEN S.A.
Contract value
no value published
Bids received
1
Published
23 Apr 2026
Awarded
22 Apr 2026
Contract start
22 Apr 2026
Contract end
23 Apr 2027estimated

More awards from this buyer